Joshua M. Eizen
Chief Operating Officer and Chief Legal Officer · AN2 Therapeutics, Inc.
- 2024
- Jul 10, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Joshua M. Eizen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robin Shane Readnour - $317K in ANTX purchases and sales in the last 12 months
- Margaret M. Fitzpatrick - $12K in ANTX purchases and sales in the last 12 months
- Sanjay Chanda - $9K in ANTX purchases and sales in the last 12 months
- Lucy Day - $9K in ANTX purchases and sales in the last 12 months
- Stephen David Prior - $7K in ANTX purchases and sales in the last 12 months
- Sarah Joanne Williams - $3K in ANTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joshua M. Eizen?
Joshua M. Eizen is a corporate insider, tracked as Chief Operating Officer and Chief Legal Officer of AN2 Therapeutics, Inc. (ANTX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Joshua M. Eizen last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 6 filings going back to 2024.
Has Joshua M. Eizen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($53K) across all tracked filings.
